You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Baxter
Merck
Medtronic
Mallinckrodt

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Patent: 9,958,442

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,958,442
Title:Sensors incorporating antibodies and methods of making and using the same
Abstract: A sensor comprising an electronic circuit electrically coupled to a type III-V semiconductor material, for example indium arsenide (InAs) and an antibody contacting the type III-V semiconductor material. The sensor produces measurable N changes in the electrical properties of the semiconductor upon antibody-antigen binding events. Electrical properties measurable by the electronic device may include resistivity, capacitance, impedance, and inductance. A method of detecting an antigen using sensors of the invention. A method of detecting a reaction of an analyte to a stimulus using sensors of the invention. Sensor arrays comprising multiple sensors of the invention.
Inventor(s): Angelo; R. Michael (Berkeley, CA), Brown; April S. (Hillsborough, NC), Wolter; Scott (Hillsborough, NC), Lampert; William V. (Raleigh, NC)
Assignee: Duke University (Durham, NC)
Application Number:13/201,181
Patent Claims:see list of patent claims

Details for Patent 9,958,442

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 004 1973-03-05   Start Trial Duke University (Durham, NC) 2029-02-11 RX search
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 003 1973-03-05   Start Trial Duke University (Durham, NC) 2029-02-11 RX search
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 002 1973-03-05   Start Trial Duke University (Durham, NC) 2029-02-11 RX search
Fresenius Kabi Usa CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017067 001 1973-03-05   Start Trial Duke University (Durham, NC) 2029-02-11 RX search
Bel Mar CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017054 002 1974-03-26   Start Trial Duke University (Durham, NC) 2029-02-11 DISCN search
Bel Mar CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017054 001 1974-03-26   Start Trial Duke University (Durham, NC) 2029-02-11 DISCN search
Ferring CHORIONIC GONADOTROPIN gonadotropin, chorionic INJECTABLE;INJECTION 017016 011 1975-06-26   Start Trial Duke University (Durham, NC) 2029-02-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Merck
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.